137 related articles for article (PubMed ID: 3827157)
1. [Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol].
Forette F; Henry-Amar M; d'Allens H; Hervy MP; Bouchacourt P; Henry JF; Pappo M
Ann Cardiol Angeiol (Paris); 1987 Feb; 36(2):103-7. PubMed ID: 3827157
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study.
Soberman J; Greenberg S; Frishman W
J Clin Hypertens; 1987 Sep; 3(3):271-7. PubMed ID: 3312501
[TBL] [Abstract][Full Text] [Related]
3. Treatment of isolated systolic hypertension with labetalol in the elderly.
Giles TD; Weber M; Bartels DW; Silberman HM; Gilderman LP; Burris JF
Arch Intern Med; 1990 May; 150(5):974-6. PubMed ID: 2184794
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension in the elderly. Comparison of the efficacy and tolerability of labetalol and nifedipine. A multicenter, randomized, single-blind study].
Decoulx M; Godon P; Pappo M; d'Allens H
Ann Cardiol Angeiol (Paris); 1990 May; 39(5):305-9. PubMed ID: 2195978
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
6. Double-blind trial of labetalol.
Kane J; Gregg I; Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
[TBL] [Abstract][Full Text] [Related]
7. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
Rouffy J; Bakir R; Chanu B; Djian F; Goy-Loeper J; Henry Amar M; Renon D; Pappo M
Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of arterial hypertension with labetalol. A polycentric study].
G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of labetalol in general medicine in aged patients with hypertension. Compliance, efficacy and safety in long-term treatment].
Hugonot R; Hugonot L; Herrero G
Ann Cardiol Angeiol (Paris); 1990 Nov; 39(9):547-53. PubMed ID: 2291621
[TBL] [Abstract][Full Text] [Related]
10. Propranolol-hydralazine combination in essential hypertension.
Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
[TBL] [Abstract][Full Text] [Related]
11. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
12. [Essential arterial hypertension and quality of life. Comparative crossed double-blind study of labetalol and captopril].
Carre A; Petetin N; Jouvent R; Baruch P; d'Allens H; Pappo M
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1269-73. PubMed ID: 2510660
[TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
[TBL] [Abstract][Full Text] [Related]
14. Postmarketing comparison of labetalol and propranolol in hypertensive patients.
Due DL; Giguere GC; Plachetka JR
Clin Ther; 1986; 8(6):624-31. PubMed ID: 3791361
[TBL] [Abstract][Full Text] [Related]
15. Labetalol in resistant hypertension.
Dargie HJ; Dollery CT; Daniel J
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
[TBL] [Abstract][Full Text] [Related]
16. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients.
Stoudemire A; Knos G; Gladson M; Markwalter H; Sung YF; Morris R; Cooper R
J Clin Psychiatry; 1990 Dec; 51(12):508-12. PubMed ID: 2258364
[TBL] [Abstract][Full Text] [Related]
17. Labetalol and nifedipine in the management of essential hypertension.
Prasad NK
J Indian Med Assoc; 1990 Jul; 88(7):188-9. PubMed ID: 2266262
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of arterial hypertension in the aged with a calcium antagonist: nicardipine].
Forette F; Bellet M; Henry JF; Hervy MP; Poyard-Salmeron C; Bouchacourt P
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1242-6. PubMed ID: 6441544
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and tolerability of cycletanine in aged patients with hypertension].
Bodak A; Gavardin T; Salom M; Tarrade T; Forette F; Jungers P; Metellus J
Therapie; 1989; 44(2):101-6. PubMed ID: 2756515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
